HIMANSHU GADGIL
Alkem's Enzene powers into US with $70 m investmentEnzene Biosciences, an Alkem Labs subsidiary, has inaugurated a new US manufacturing plant. The facility is located in New Jersey. This ven...
Alkem subsidiary Enzene launches adalimumab biosimilar in IndiaEnzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.- Intas Pharmaceutical launches low cost drug 'Mabtas' for cancer treatmentIntas Pharmaceutical today said it has launched 'Mabtas' a new low cost drug for treating cancer in India.
- Load More